In Law360's Weekly Verdict: Firm Named Legal Lions

Articles & Press

Hughes Hubbard & Reed LLP • A New York Limited Liability Partnership

One Battery Park Plaza • New York, New York 10004-1482 • +1 (212) 837-6000

Attorney advertising. Readers are advised that prior results do not guarantee a similar outcome. No aspect of this advertisement has been approved by the Supreme Court of New Jersey. For information regarding the selection process of awards, please visit https://www.hugheshubbard.com/legal-notices-methodologies.

May 9, 2019 - James Dabney and his team were recognized in "Law360's Weekly Verdict: Legal Lions & Lambs."

A single sentence in a patent settlement prevents Amgen Inc. from halting sales of a generic version of its blockbuster calcium-control drug Sensipar, a Delaware federal judge ruled in an opinion released Friday, handing a win to attorneys at Hughes Hubbard & Reed LLP and Farnan LLP who represented generic drugmaker Cipla Ltd. Cipla is represented by Sue L. Robinson, Brian E. Farnan and Michael J. Farnan of Farnan LLP, and James W. Dabney, Patrice P. Jean, Dina Hoffer, Deanne K. Cevasco, David E. Lansky and Lynn M. Russo of Hughes Hubbard & Reed LLP.

Click here to view full article.